P2X4 purinergic receptors offer a therapeutic target for aggressive prostate cancer-Reference-Cited by-同舟云学术

P2X4 purinergic receptors offer a therapeutic target for aggressive prostate cancer

Published:2021-11-25 Issue:2 Volume:256 Page:149-163
ISSN:0022-3417
Container-title:The Journal of Pathology
language:en
Short-container-title:The Journal of Pathology

Author:

Maynard Janielle P¹²^ORCID,Lu Jiayun³,Vidal Igor¹,Hicks Jessica¹,Mummert Luke¹,Ali Tamirat¹,Kempski Ryan¹,Carter Ayanna M.¹,Sosa Rebecca Y¹,Peiffer Lauren B¹⁴,Joshu Corinne E²³,Lotan Tamara L¹²⁵^ORCID,De Marzo Angelo M.¹²⁵,Sfanos Karen S¹²⁵^ORCID

Affiliation:

1. Department of Pathology Johns Hopkins University School of Medicine Baltimore MD USA

2. Sidney Kimmel Comprehensive Cancer Center Baltimore MD USA

3. Department of Epidemiology Johns Hopkins Bloomberg School of Public Health Baltimore MD USA

4. Department of Molecular and Comparative Pathobiology Johns Hopkins University School of Medicine Baltimore MD USA

5. Department of Urology, James Buchanan Brady Urological Institute Johns Hopkins University School of Medicine Baltimore MD USA

Funder

American Cancer Society

National Institutes of Health

Prostate Cancer Foundation

Publisher

Wiley